Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Clinical trial NCT02805075 · COMPLETED

Trial details

NCT number: NCT02805075
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematopoietic and Lymphoid Cell Neoplasm Recurrent Hematologic Malignancy

Start date: 2016-06-01
Primary completion: 2017-11-17
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.